Dr. Banfield is a distinguished Clinical Pharmacology leader with an impressive track record spanning over 25 years in the pharmaceutical industry. Throughout his career, he has demonstrated a relentless commitment to maximizing the efficiency and effectiveness of clinical pharmacology, holding scientific and leadership positions at renowned organizations such as Pfizer, where he served as Vice President, and Amgen, where he excelled as Executive Director. Dr. Banfield’s extensive industry experience has equipped him with invaluable insights into drug development at all levels, enabling him to deliver mission-critical results with unparalleled expertise.

With a proven proficiency in the development of both small molecules and biological products, Dr. Banfield has emerged as a trusted authority in program management and providing expert domain knowledge. He is a staunch advocate for leveraging modeling and simulations to inform rational decision-making throughout the drug development process, contributing to the advancement of innovative therapeutic solutions.

In addition to his impactful contributions to the field, Dr. Banfield has authored or co-authored 65 publications, posters, and abstracts, further solidifying his reputation as a thought leader in Clinical Pharmacology. His groundbreaking research has earned him recognition in the form of two patents, underscoring his innovative approach to pharmaceutical science.

Dr. Banfield holds a Ph.D. in Pharmacy with a specialization in Pharmacokinetics from the University of Manchester, an M.Sc. in Pharmacy from the University of Toronto, and a B.Sc. in Chemistry from the University of the West Indies. He further enriched his academic pursuits through postdoctoral research at the University of Washington, where he focused on Pharmacy under the mentorship of esteemed professors René Levy and John Slatery. Dr. Banfield’s multidisciplinary background and unwavering dedication to advancing pharmaceutical research make him a distinguished leader in the field.